L-Citrulline in Maternal–Fetal and Neonatal Health: Metabolic Mechanisms and Emerging Therapeutic Applications
Open Access
Abstract
L-citrulline is a non-protein amino acid with critical roles in perinatal and neonatal physiology through the intestinal–renal arginine–citrulline axis and nitric oxide (NO) production. During pregnancy, L-citrulline supports placental angiogenesis, vascular adaptation, and fetal growth through augmentation of arginine availability and endothelial NO production. In neonates, particularly preterm infants, developmental immaturity of citrulline and arginine synthesis contributes to hypoargininemia and may increase susceptibility to necrotizing enterocolitis, bronchopulmonary dysplasia with pulmonary hypertension, sepsis, and impaired intestinal function. Although L-citrulline has emerged as a promising modulator of NO bioavailability, prior reviews have largely focused on either adult cardiovascular disease or isolated neonatal applications, with limited integration of its mechanistic and translational relevance across the perinatal and neonatal continuum. Collectively, current evidence supports L-citrulline as a promising translational target in maternal–fetal and neonatal medicine because of its central role in vascular, inflammatory, and metabolic regulation. However, adequately powered clinical trials are needed to define optimal dosing, timing, patient selection, and long-term outcomes before routine clinical implementation can be recommended. This review provides a comprehensive evaluation of L-citrulline metabolism and its therapeutic potential from pregnancy through neonatal life, with emphasis on the intestinal–renal arginine–citrulline axis, endothelial function, and NO-mediated vascular regulation. We specifically examine the role of citrulline in key pathophysiologic mechanisms underlying maternal and neonatal disease, including endothelial dysfunction, impaired NO bioavailability, inflammation, oxidative stress, and abnormal placental vascular remodeling.Keywords
This publication has 55 references indexed in Scilit:
- Potential therapeutic uses of L‐citrulline beyond genetic urea cycle disordersJournal of Inherited Metabolic Disease, 2024
- CHronic hypERtension and L-citRulline studY (CHERRY): an Early-Phase Randomised Controlled Trial in PregnancyReproductive Sciences, 2023
- Pathophysiology of Preeclampsia and L-Arginine/L-Citrulline Supplementation as a Potential Strategy to Improve Birth Outcomes2023
- Citrulline enteral administration markedly reduces immunosuppressive extrafollicular plasma cell differentiation in a preclinical model of sepsisEuropean Journal of Immunology, 2023
- Pharmacokinetics of l-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary HypertensionPediatric Drugs, 2022
- Therapeutic Potential of Citrulline as an Arginine Supplement: A Clinical Pharmacology ReviewPediatric Drugs, 2020
- Effect of Combination l-Citrulline and Metformin Treatment on Motor Function in Patients With Duchenne Muscular DystrophyJAMA Network Open, 2019
- Plasma Citrulline Concentrations in Neonates With or Without Gastrointestinal Disease During Periods of Parenteral and Enteral NutritionJournal of Parenteral and Enteral Nutrition, 2019
- Suggested guidelines for the diagnosis and management of urea cycle disorders: First revisionJournal of Inherited Metabolic Disease, 2019
- Almost all about citrulline in mammalsAmino Acids, 2005